Jove
Visualize
Contact Us

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transition from pulsed dose rate to high dose rate brachytherapy: Experience of a single centre.

Brachytherapy·2025
Same author

Can we predict the cardiac benefit of deep inspiration breath hold for left breast and regional nodal irradiation?

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2023
Same author

Impact of external beam pelvic radiotherapy of endometrial carcinoma: A focus on chronic digestive toxicity.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2022
Same author

[Dose optimization in 3D pulsed dose rate brachytherapy for patients with locally advanced cervical cancer: A French multicenter phase II trial].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2021
Same author

Interstitial multi-catheter breast brachytherapy: Technical aspects and experience feedback in a comprehensive cancer center.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2021
Same author

[Comparison of survival and chronic gastrointestinal toxicities in patients with locally advanced cervical cancer, treated by conventional or intensity-modulated radiation technique].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2017
Same journal

Comparative study of interstitial brachytherapy and intensity-modulated radiotherapy as tumour bed boost after conservative surgery for breast cancer: Toxicity and cosmetic outcomes.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

White paper on radiotherapy in France: Ten objectives to strengthen one of the major modalities of cancer treatment.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Contemporary survival outcomes of patients with isolated nodal recurrences of breast cancer: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Factors affecting the stability of deep inspiration breath-holding in radiotherapy for left-sided breast cancers.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Incidence and outcomes of radiation-induced sarcomas following radiotherapy for low-grade non-Hodgkin lymphomas: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Radiotherapy as a curative strategy for primary pleural indolent lymphomas: Analytical guidelines based on literature and an illustrative population-based case series.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 14, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

[Brachytherapy for endometrial cancers].

C Charra-Brunaud1, R Mazeron

  • 1Service de curiethérapie, centre Alexis-Vautrin, 6, avenue de Bourgogne, 54100 Vandœuvre-lès-Nancy, France.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|February 5, 2013
PubMed
Summary
This summary is machine-generated.

Brachytherapy is crucial for endometrial cancer patients, both after surgery to prevent vaginal cuff recurrences and as an alternative treatment for those unable to undergo surgery. Techniques differ significantly based on the clinical situation.

More Related Videos

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Related Experiment Videos

Last Updated: May 14, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Area of Science:

  • Gynecologic Oncology
  • Radiation Oncology

Background:

  • Surgery is the primary treatment for endometrial cancer.
  • Brachytherapy is essential in managing endometrial cancer patients.
  • It is used in postoperative care and as an alternative for inoperable patients.

Purpose of the Study:

  • To highlight the role of brachytherapy in endometrial cancer management.
  • To differentiate brachytherapy techniques in various clinical scenarios.

Main Methods:

  • Postoperative brachytherapy for vaginal cuff recurrence prevention.
  • Brachytherapy as a standalone or adjuvant treatment for medically inoperable patients, potentially with external beam radiation therapy.

Main Results:

  • Brachytherapy effectively prevents vaginal cuff recurrences post-surgery.
  • It offers a viable treatment alternative for patients unsuitable for surgery.
  • Distinct brachytherapy techniques are employed depending on the patient's condition and treatment goal.

Conclusions:

  • Brachytherapy is a versatile and vital component in the multidisciplinary approach to endometrial cancer.
  • Tailored brachytherapy techniques are critical for optimizing outcomes in different patient populations.